Severe eosinophilia associated with hydroxychloroquine use in a patient with COVID-19
- 1 January 2021
- journal article
- letter
- Published by Medknow in Asian Pacific Journal of Tropical Medicine
- Vol. 14 (6), 285-286
- https://doi.org/10.4103/1995-7645.314112
Abstract
Asian Pacific Journal of Tropical Medicine, Editorial office of Hainan Medical UniversityKeywords
This publication has 5 references indexed in Scilit:
- Characterizing the adverse dermatologic effects of hydroxychloroquine: A systematic reviewJournal of the American Academy of Dermatology, 2020
- Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID‐19 eraDermatologic Therapy, 2020
- Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquineDermatologic Therapy, 2020
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatologyNature Reviews Rheumatology, 2020
- Pustular DRESS Syndrome Secondary to Hydroxychloroquine With EBV Reactivation2019